Developing as a noteworthy advance in the fight against obesity, this medication is generating considerable interest . It combines effects of two recognized GLP-1 receptor agonists, dulaglutide , and an additional glucose-dependent hormonal component. Initial patient data have demonstrated significant body reduction in patients with obesity , poss